| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 266, Issue 6 2468-H2475, Copyright © 1994 by American Physiological Society
ARTICLES |
H. A. Rockman, S. P. Wachhorst, L. Mao and J. Ross Jr
Department of Medicine, University of California San Diego School of Medicine, La Jolla 92093.
There is increasing evidence that the renin-angiotensin system may play a important role in cardiac hypertrophy. To assess the role of angiotensin II in the induction of cardiac hypertrophy, three groups of adult mice were subjected to left ventricular pressure overload by transverse aortic constriction (TAC). For the next 7 days the groups received either the specific angiotensin II subtype 1 receptor (AT1) antagonist (losartan, 1.05 g/l; n = 17), an angiotensin enzyme inhibitor (captopril, 2 g/l; n = 17), or no treatment (n = 22) administered in the drinking water and compared with three similarly treated sham-operated groups (n = 7 each). TAC resulted in a significant increase in heart weight-to-body weight ratio (0.634 +/- 0.087 vs. 0.525 +/- 0.039, g/g x 100, P < 0.05), which was prevented by losartan (0.506 +/- 0.069, g/g x 100, P < 0.0001) despite similar hemodynamic load (proximal systolic pressure 146 +/- 31 vs. 136 +/- 32 mmHg, untreated vs. losartan, P = NS). Proximal systolic pressure was positively correlated with the development of ventricular hypertrophy. In the presence of AT1-receptor blockade, the increase in heart weight-to-body weight ratio at any given systolic pressure was significantly attenuated compared with untreated TAC mice. The increase in heart weight-to-body weight ratio was also significantly attenuated by captopril compared with untreated banded controls (0.542 +/- 0.091, g/g x 100, P = 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  M. Zhao, A. Chow, J. Powers, G. Fajardo, and D. Bernstein Microarray analysis of gene expression after transverse aortic constriction in mice Physiol Genomics, September 16, 2004; 19(1): 93 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hara, K. Ono, M.-W. Hwang, A. Iwasaki, M. Okada, K. Nakatani, S. Sasayama, and A. Matsumori Evidence for a Role of Mast Cells in the Evolution to Congestive Heart Failure J. Exp. Med., February 4, 2002; 195(3): 375 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Segar, G. B. Dalshaug, K. A. Bedell, O. M. Smith, and T. D. Scholz Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R2037 - R2047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nakamura, D. G. Rokosh, M. Paccanaro, R. R. Yee, P. C. Simpson, W. Grossman, and E. Foster LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1104 - H1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Lisy, M. M. Redfield, S. Jovanovic, M. Jougasaki, A. Jovanovic, H. Leskinen, A. Terzic, and J. C. Burnett Jr Mechanical Unloading Versus Neurohumoral Stimulation on Myocardial Structure and Endocrine Function In Vivo Circulation, July 18, 2000; 102(3): 338 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mazzolai, T. Pedrazzini, F. Nicoud, G. Gabbiani, H.-R. Brunner, and J. Nussberger Increased Cardiac Angiotensin II Levels Induce Right and Left Ventricular Hypertrophy in Normotensive Mice Hypertension, April 1, 2000; 35(4): 985 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Meguro, C. Hong, K. Asai, G. Takagi, T. A. McKinsey, E. N. Olson, and S. F. Vatner Cyclosporine Attenuates Pressure-Overload Hypertrophy in Mice While Enhancing Susceptibility to Decompensation and Heart Failure Circ. Res., April 2, 1999; 84(6): 735 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koide, B. A. Carabello, C. C. Conrad, J. M. Buckley, G. DeFreyte, M. Barnes, R. J. Tomanek, C.-C. Wei, L. J. Dell'Italia, G. Cooper IV, et al. Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H350 - H358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kunisada, E. Tone, Y. Fujio, H. Matsui, K. Yamauchi-Takihara, and T. Kishimoto Activation of gp130 Transduces Hypertrophic Signals via STAT3 in Cardiac Myocytes Circulation, July 28, 1998; 98(4): 346 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Akhter, L. M. Luttrell, H. A. Rockman, G. Iaccarino, R. J. Lefkowitz, and W. J. Koch Targeting the Receptor-Gq Interface to Inhibit in Vivo Pressure Overload Myocardial Hypertrophy Science, April 24, 1998; 280(5363): 574 - 577. [Abstract] [Full Text]
|
|
|
|
|
|
M. Hamawaki, T. M. Coffman, A. Lashus, M. Koide, M. R. Zile, M. I. Oliverio, G. Defreyte, G. Cooper IV, and B. A. Carabello Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H868 - H873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Harada, H. Itoh, O. Nakagawa, Y. Ogawa, Y. Miyamoto, K. Kuwahara, E. Ogawa, T. Igaki, J. Yamashita, I. Masuda, et al. Significance of Ventricular Myocytes and Nonmyocytes Interaction During Cardiocyte Hypertrophy : Evidence for Endothelin-1 as a Paracrine Hypertrophic Factor From Cardiac Nonmyocytes Circulation, November 18, 1997; 96(10): 3737 - 3744. [Abstract] [Full Text]
|
|
|
|
|
|
J. Pan, K. Fukuda, H. Kodama, S. Makino, T. Takahashi, M. Sano, S. Hori, and S. Ogawa Role of Angiotensin II in Activation of the JAK/STAT Pathway Induced by Acute Pressure Overload in the Rat Heart Circ. Res., October 19, 1997; 81(4): 611 - 617. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Segar, T. D. Scholz, K. A. Bedell, O. M. Smith, D. J. Huss, and E. N. Guillery Angiotensin AT1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1501 - R1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Obayashi, M. Yano, M. Kohno, S. Kobayashi, T. Tanigawa, K. Hironaka, T. Ryouke, and M. Matsuzaki Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1824 - H1831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-J. Choi, W. J. Koch, J. J. Hunter, and H. A. Rockman Mechanism of beta -Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased beta -Adrenergic Receptor Kinase J. Biol. Chem., July 4, 1997; 272(27): 17223 - 17229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ross Jr On Variations in the Cardiac Hypertrophic Response to Pressure Overload Circulation, March 18, 1997; 95(6): 1349 - 1351. [Full Text]
|
|
|
|
|
|
T. Ogawa, W. Linz, M. Stevenson, B. G. Bruneau, M. L. Kuroski de Bold, J. H. Chen, H. Eid, B. A. Scholkens, and A. J. de Bold Evidence for Load-Dependent and Load-Independent Determinants of Cardiac Natriuretic Peptide Production Circulation, June 1, 1996; 93(11): 2059 - 2067. [Abstract] [Full Text]
|
|
|
|
|
|
G. Xiao, S. Mao, G. Baumgarten, J. Serrano, M. C. Jordan, K. P. Roos, M. C. Fishbein, and W. R. MacLellan Inducible Activation of c-Myc in Adult Myocardium In Vivo Provokes Cardiac Myocyte Hypertrophy and Reactivation of DNA Synthesis Circ. Res., December 7, 2001; 89(12): 1122 - 1129. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
